the aid library

LIST OPTIONS

Filter

1246

COVID-19 and work: Staying healthy and safe at work during the COVID-19 pandemic

Open WHO; World Health Organization WHO (2021) C2

Workplaces have played an important role in both the spread and mitigation of the COVID-19 pandemic throughout the world. Being provided a healthy and safe workplace throughout the pandemic ... beyond is a human right. Maintaining open, safe and healthy workplaces is of vital importance to protecting livelihoods, wellbeing and public health. Critical public health measures can help protect workers, their clients, and the community at large. Through an introduction and 5 modules, this course aims to guide workers and their representatives, business leaders, employers, managers and occupational health and safety professionals on how to protect themselves and their workplace during the COVID-19 pandemic. more

Download (162)

View PDF (182)

Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases

World Health Organization WHO (2018) C_WHO

Práticas de prevenção e controle de infecções para o tratamento de pacientes em estabelecimentos não tradicionais, com foco no novo coronavírus (COVID-19)

Pan American Health Organization PAHO (2020) C_WHO

Objetivos: • Fornecer recomendações para as práticas de prevenção e controle de infecções (PCI) a serem usadas durante atendimento em estabelecimentos não tradicionais, no contexto da doença do novo coronavírus (COVID-19). Estas recomend... more

Download (214)

View PDF (199)

Liberia: How reinforced community health structures and capitalizing on lessons learned from the Ebola virus epidemic of 2014–16 helped the country respond to the challenge of its second major disease

World Health Organization WHO (2021) C_WHO

Download (177)

View PDF (154)

COVID-19 Planning Guide for Adapting Risk Communication and Community Engagement as Public Health and Social Measures Shift

IFRC; Save the Children andJohn Hopkins Center for Communication Programs (2020) CC

With Safety Tips for Conducting Community Meetings Updated July 2020 This document includes key Risk Communication and Community Engagement (RCCE) considerations during shifting lockdown measures, safety measures for conducting in-person community... more

Syrian Public Health after COVID-19: Entry Points and Lessons Learned from the Pan

Center for Operational Analysis and Research COAR (2021) CC

March 2021

Finding the Balance: Public Health and Social Measures in Mozambique

Partnership for Evidence-Based Response to COVID-19 (PERC) (2021) CC

This report describes findings from a telephone survey with 1,333 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households ... more

Community tuberculosis screening, testing and care, Uganda

World Health Organisation (WHO) (2024) C_WHO

Objective To assess the effectiveness of a community-based tuberculosis and leprosy intervention in which village health teams and health workers conduct door-to-door tuberculosis screening, targete... more

Download (1764)

View PDF (1235)

INSTRUMENT STERILIZATION PROCESS

Inter-agency Working Group on Reproductive Health in Crises (2014)

Accessed June 2014 Adapted by PATH from: EngenderHealth. Infection Prevention: a reference booklet for health care providers . New York: EngenderHealth; 2001. Available at: http://www.engender... more

Guideline on management of pneumonia and diarrhoea in children up to 10 years of age

World Health Organization WHO (2024) C_WHO

Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia ... diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preventable deaths globally in 2021. Existing World Health Organization (WHO) guidance on the clinical management of pneumonia and diarrhoea has mainly focused on children less than 5 years of age. more

Download (973)

View PDF (1423)

A guide for the quality assurance of single use in injection equipment

World Health Organization (2003)

Download (673)

View PDF (976)

Injection providers' guide for safe injections

World Health Organization WHO (2017) C_WHO

Download (1043)

View PDF (1209)

Utilisation de la ventilation naturelle pour lutter contre les infections en milieu de soins

J. Atkinson, Y. Chartier, C.L.Pessoa-Silva, et.al Organisation Mondiale de la Santé (2009)

Download (408)

View PDF (663)

Regional action plan for viral hepatitis in South-East Asia: 2016-2021

World Health Organization (WHO), Regional Office for South-East-Asia (2016) C_WHO

With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable ... sustainable and allow for innovations for acceleration and reaching out to all in need with health services. A major reduction in prices of newer drugs to potentially cure hepatitis C offers an added opportunity to work towards its elimination. more

Cleaning and disinfection of environmental surfaces in the context of COVID-19
recommended

World Health Organisation (2020) C_WHO

The purpose of this document is to provide guidance on the cleaning and disinfection of environmental surfaces in the context of COVID-19. This guidance is intended for health care professionals, public health professionals ... health authorities that are developing and implementing policies and standard operating procedures (SOP) on the cleaning and disinfection of environmental surfaces in the context of COVID-19. more

Download (290)

View PDF (386)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO

Community Engagement During Public Health Emergencies Like COVID-19: An Action Framework and Toolkit

Bangladesh Red Crescent Society; BRAC; Government of Bangladesh; UN Children's Fund UNICEF; UN Women; World Health Organization WHO (2023) CC

This handbook offers a simple framework of action for actors in local government, and in particular, health leaders such as Civil Surgeons (CSs) and Upazila Health ... Family Planning Officers (UHFPQOs), to take ownership and leadership to combat COVID-19 at each district and upazila respectively, with support and guidance from elected representatives and local administration, and through effective engagement of various segments of society including informal health care providers, religious leaders, journalists, police and law enforcement agencies, etc. The toolkit draws extensively from the experiences in Chapainawabganj, Savar and other areas and contains relevant best practises that have already proven effective in these places, which should be readily adaptable to various contexts. It is important to note that while this framework has been developed in the context of COVID-19 and with related best practises, it is by no means limited to COVID-19 response. Indeed, the experience from Savar shows that the same approach has proven extremely effective in combating the dengue outbreak and the severe floods in 2020, and hence can be used to combat future public health emergencies in Bangladesh and other countries having similar contexts. more

¿Qué es la tuberculosis? - Enfermedad y síntomas

Draw my life en espanol Youtube (2024) C2

The video titled "¿QUÉ ES LA TUBERCULOSIS? - ENFERMEDAD y SÍNTOMAS" (What is Tuberculosis? - Disease and Symptoms) provides an overview of tuberculosis (TB), detailing its causes, transmission methods, symptoms, ... treatment options. It emphasizes the importance of early detection and treatment to prevent the spread of TB and highlights the global impact of the disease. The video also discusses preventive measures and the significance of public awareness in combating tuberculosis. more

External Link (192)

Lessons Learnt from the Marburg Virus Disease (MVD) Outbreak in Tanzania

Africa CDC (2023) C_CDC

On March 16, 2023, the Tanzania Ministry of Health declared an outbreak of an unidentified illness in Bukoba district, Kagera region. A group of seven individuals presented with fever, vomiting, bleeding from various body orifices, and kidney failur... more

Cleaning and disinfection of environmental surfaces in the context of COVID-19 recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings recommended

Cleaning and disinfection of environmental surfaces in the context of COVID-19
recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended